DASATINIB, Placebo
DASAHIVCURE
Phase 2 small_molecule active
Quick answer
DASATINIB, Placebo for Asymptomatic patients with recent HIV-1 infection is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Asymptomatic patients with recent HIV-1 infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active